Fattouche, M.; Belaidi, S.; Abchir, O.; Al-Shaar, W.; Younes, K.; Al-Mogren, M.M.; Chtita, S.; Soualmia, F.; Hochlaf, M.
ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Pharmaceuticals 2024, 17, 1712.
https://doi.org/10.3390/ph17121712
AMA Style
Fattouche M, Belaidi S, Abchir O, Al-Shaar W, Younes K, Al-Mogren MM, Chtita S, Soualmia F, Hochlaf M.
ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Pharmaceuticals. 2024; 17(12):1712.
https://doi.org/10.3390/ph17121712
Chicago/Turabian Style
Fattouche, Maroua, Salah Belaidi, Oussama Abchir, Walid Al-Shaar, Khaled Younes, Muneerah Mogren Al-Mogren, Samir Chtita, Fatima Soualmia, and Majdi Hochlaf.
2024. "ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B" Pharmaceuticals 17, no. 12: 1712.
https://doi.org/10.3390/ph17121712
APA Style
Fattouche, M., Belaidi, S., Abchir, O., Al-Shaar, W., Younes, K., Al-Mogren, M. M., Chtita, S., Soualmia, F., & Hochlaf, M.
(2024). ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Pharmaceuticals, 17(12), 1712.
https://doi.org/10.3390/ph17121712